🚀Again exciting times ahead! Rejuvenate Biomed is ready to meet you at the next week LSX World Congress in Boston. Our founder & CEO Ann Belien, PhD will be sharing her insights during the panel discussion on Scaling and Commercialisation on Wednesday September 11th, from 11:00am – 11:40am ET. 🤝We can’t wait to connect with industry leaders and innovators as we continue our journey to revolutionize the future of healthy aging. Looking forward to seeing you there! #LSXWorld #biotech #leadership #healthyaging
Rejuvenate Biomed
Biotechnology Research
Diepenbeek, Flemish Region 2,503 followers
We envision a future where people stay healthy for life
About us
Rejuvenate Biomed is a clinical-stage company dedicated to the discovery and development of therapeutics to prevent or delay the onset of multiple age-related diseases. Founded in 2017, Rejuvenate Biomed is a privately-held platform and pipeline company developing safe and proprietary combination drugs that help people healthy for life. By using platform technologies, Rejuvenate Biomed identifies safe compounds that influence the aging process. Novel combination drugs are discovered that have the potential to prevent or delay the onset of multiple age-related diseases. Rejuvenate Biomed confirms prediction data in preclinical models and in clinical studies. Rejuvenate Biomed’s lead drug candidate RJx-01 is currently in Phase 1b for the treatment of sarcopenia, the progressive age-associated loss of muscle function and mass.
- Website
-
https://www.rejuvenatebiomed.com/en
External link for Rejuvenate Biomed
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Diepenbeek, Flemish Region
- Type
- Privately Held
- Founded
- 2017
- Specialties
- Healthcare, Healthspan, Aging, Mouse, Sarcopenia, C. elegans, Research, Drug development, Drug discovery, and Clinical trials
Locations
-
Primary
Wetenschapspark 13
Diepenbeek, Flemish Region 3590, BE
-
One Broadway
Cambridge, MA 02142, US
Employees at Rejuvenate Biomed
-
Glenn Van Dael
Managing Partner | Life Sciences & Healthcare | Consultancy - Digital - PM | @ Phoenx
-
Ann Belien, PhD
Founder and CEO of Rejuvenate Biomed | Translating Fundamental Insights into Healthy Aging Therapies
-
Annick Van Nijverseel
freelance management assistant Biotech/Pharma - bringing your organization to the next level, sustainable for the future, providing the right support…
-
Evi Mercken
Chief Scientific Officer at Rejuvenate Biomed
Updates
-
🌟 We are honored to share that Rejuvenate Biomed has the privilege of presenting at the 1st Scientific Meeting of the Canadian Translational Geroscience Network! 🧬 CTGN is a network dedicated to understanding and applying geroscience principles to enhance the health and well-being of aging population across Canada. Being part of this inaugural meeting provides great opportunities to engage in dynamic exchanges among academics, industry stakeholders, healthcare professionals, and advocates for healthy aging. Proud to announce that Ann Belien, PhD will be presenting on day 1 and Jeroen Aerssens, PhD on day 2. 📅 September 05-06, 2024 📍 Research Institute of the McGill University Health Center 🌐 https://lnkd.in/euvur_xb A heartfelt thank you to Dr. Gustavo Duque, the organizers, fellow presenters, and all attendees for creating an inspiring atmosphere that fosters collaboration and innovation in geroscience. Together, we are paving the way for a healthier future for all. Looking forward to the continued advancements and collaborations in this exciting field! #CTGN #Geroscience #TranslationalResearch #Aging #Longevity #ScientificMeeting #Collaboration #Innovation
-
Reflecting on a wonderful #ARDD2024 edition in the beautiful Ceremonial hall of the University of Copenhagen, it’s exciting to see how this conference continues to grow every year, setting new attendance records and reaching new heights. Rejuvenate Biomed was proud to have supported this groundbreaking conference as a Tier 3 sponsor, and to be part of the community that is driving innovation in aging research and drug discovery. We were thrilled to have Jeroen Aerssens, PhD represent Rejuvenate Biomed as a speaker, sharing our latest insights and innovations with an international audience. A big thank you to Daniela Bakula, Morten Scheibye-Knudsen Alex Zhavoronkov and the entire organizing team for their incredible efforts. #ARDD2024 #ARDD2024 #AgingResearch #Pharma #Biotech #Innovation
-
Rejuvenate Biomed is proud to announce our sponsorship and speaker opportunity of the prestigious Aging Research & Drug Discovery Meeting Research & Drug Discovery (ARDD) Meeting 2024 in Copenhagen. As pioneers in the field of healthy aging, we are committed to advancing groundbreaking research and innovative therapies that have the potential to transform lives. The ARDD Meeting is a premier event that brings together leading scientists, clinicians, and industry experts to share the latest advancements and foster collaboration in the pursuit of extending healthy lifespans. Our sponsorship underscores our dedication to supporting the scientific community and driving forward the frontier of aging research. We are eager to engage with fellow researchers, discuss cutting-edge discoveries, and explore new opportunities for collaboration. Many thanks to the amazing chairs of ARDD Morten Scheibye-Knudsen, Daniela Bakula and Alex Zhavoronkov. Join us as we work together to unlock the secrets of aging and pave the way for a healthier, longer future! 🌱✨ #RejuvenateBiomed #ARDDMeeting #LongevityResearch #HealthyAging #ScientificInnovation #Collaboration
-
We are excited to announce a partnership with SAS to develop a user-friendly #DrugRepurposing #DiscoveryTool for researchers and scientists. The tool will uncover medically relevant insights about drugs, diseases, and biological networks, through fast and systematic explorations of hidden biological patterns. It will be developed on SAS® Viya®, a powerful cloud-native #ArtificialIntelligence (AI) and data platform. 🌟 Together, we are committed to advancing healthcare and accelerating scientific breakthroughs for age-related, metabolic and other diseases.🤝 Read the full press release here: https://lnkd.in/ej-KixjR #aging #Biotechnology #HealthyAging #DrugDevelopment #AIinDrugDiscovery #SASViya #HealthcareInnovation #AgeRelatedDiseases #Bioinformatics
-
🌟 Our Founder & CEO Ann Belien, PhD, is honored to be interviewed alongside John Dunlop of Aliada Therapeutics and Josh Shafer of Zevra Therapeutics for a BioSpace article, sharing their career journeys in the biopharma industry. 📚 Discover how every step of Ann's journey has been a learning experience, shaping her leadership style and driving innovation at Rejuvenate Biomed. 👏 Congratulations to BioSpace and Angela Gabriel for spotlighting these influential voices in our field! #Leadership #Biopharma #Innovation #CareerGrowth #Healthcare
John Dunlop, Chief Science Officer of Aliada Therapeutics, Ann Beliën, CEO and Founder of Rejuvenate Biomed, and Josh Shafer, Chief Commercial Officer and Executive Vice President of Business Development at Zevra Therapeutics share their career journeys with BioSpace. Together, their careers combined include working at companies including Amgen, AstraZeneca, The Janssen Pharmaceutical Companies of Johnson & Johnson, Pfizer and Takeda. https://hubs.li/Q02H58Hy0 #careeradvice #pharma #biospace
-
🎉 Exciting News! We’ve Moved to a New Office! 🎉 We are thrilled to announce that Rejuvenate Biomed has officially moved to our brand new office space at BioVille! ✨ This move represents a significant milestone in our journey, and we couldn’t be more excited to share it with you. This new location is a reflection of our growth, ambitions, and commitment to providing the best environment for our team. The beautiful office, collaborative spaces and brand new lab, will empower us to continue innovating and achieving new heights. A heartfelt thank you to everyone who are supporting us along the way, our dedicated team, partners and supporters. Here's to our continued success 💐 https://lnkd.in/gUgF57S5 #pomlimburg #healthcampus #limburgdc #lifesciences #biotech #growingcompany #healthinnovation #healthyaging
-
👋 We are very pleased and honored to announce that Jeroen Aerssens, PhD has joined Rejuvenate Biomed as Chief Development Officer. Jeroen brings a wealth of experience in pharmaceutical R&D, encompassing preclinical drug discovery, translational research and clinical development. With over 25 years in pharma, he has a proven track record in building and leading research teams in the field of biomarkers and clinical translational science. 🚀 “We are delighted to welcome Jeroen to our team! His exceptional expertise in drug discovery and development will be instrumental in propelling our mission of pioneering innovative solutions for healthy aging. With Jeroen on board, our leadership will enhance our capabilities and drive our mission forward. We are confident that his leadership will support in scaling our operations and explore new development opportunities”, Ann Belien, PhD, Founder & CEO of Rejuvenate Biomed https://lnkd.in/eKtWJZSd #healthyaging #biotech #teamwork #growingcompany #leadership #healthinnovation #lifesciences
-
Our colleague Dr. Jens Frickel is attending & presenting at the Data Science for Planetary and Human Health conference, in Copenhagen, 10-12 June https://lnkd.in/eFua2v4x 🌍💡 Looking forward to discuss and discover the latest developments in the field of data science, data management, and communication. We are also proud to announce that Jens has been selected for a poster session! 🎉 If you are at the conference, make sure to stop by poster 73 to learn more about the innovative work happening at Rejuvenate Biomed #RejuvenateBiomed #DataScience #HealthInnovation #CopenhagenConference #Sciencecluster
-
Rejuvenate Biomed is really excited to bring first sarcopenia patient data to our meetings at BIO in San Diego. Discover how our novel approach to age-related diseases can make a difference in keeping people healthy as long as possible. 🚩 Let's connect in the BIO One-on-One Partnering tool and meet Frederic Godderis, Chief Strategy Officer, Lizzy-Anne (Lisiane) Neven, CFO and Dr. Ann Belien, Founder & CEO. 👉 Follow our company presentation on Monday June 3rd at 3:15pm local time in Theater 4. Looking forward to connecting with you during the week. 🌟 #BIO2024 #Biotech #InvestorEngagement #businessdevelopment #healthyaging